UEMATSU TOSHITAKA

Profiles

Profiles

• 氏名

  UEMATSU TOSHITAKA

Affiliation

• Department of Urology

Research achievements

Published Papers

Original paper
• 23(2), 338-346, Apr. 2018

  DOI
• 5(1), e000666, Jan. 2018

  DOI
• 5-Fluorouracil-based adjuvant chemotherapy improves the clinical outcomes of patients with lymphovascular invasion of upper urinary tract cancer and low expression of dihydropyrimidine dehydrogenase., Narimatsu Takahiro;Kambara Tsunehito;Abe Hideyuki;Uematsu Toshitaka;Tokura Yuumi;Suzuki Issei;Sakamoto Kazumasa;Takei Kouhei;Nishihara Daisaku;Nakamura Gaku;Kokubun Hidetoshi;Yuki Hideo;Betsunoh Hironori;Kamai Takao, Oncology letters, 17(5), 4429-4436, May 2019

  DOIPermalink
• 腎摘除術を要した重症腎感染症の後方視的検討, 小田 侑希(奈良県立医科大学 泌尿器科), 堀 俊太, 西村 伸隆, 吉田 貴法, 植松 稔貴, 大森 千尋, 三宅 牧人, 穴井 智, 鳥本 一匡, 青木 勝也, 田中 宣道, 米田 龍生, 藤本 清秀, Hinyokika kiyo. Acta urologica Japonica, 67(8), 355-358, Aug. 2021

  DOIPermalink
• Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation., Kamai Takao;Murakami Satoshi;Arai Kyoko;Nishihara Daisaku;Uematsu Toshitaka;Ishida Kazuyuki;Kijima Toshiki, BMC cancer, 22(1), 289, 18 Mar. 2022

  DOIPermalink
• Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients., Takei Kohei;Kijima Toshiki;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Betsunoh Hironori;Yashi Masahiro;Kamai Takao, Cancers, 15(23), 26 Nov. 2023

  DOI

Review paper
• 14, 85-90, Dec. 2022
• 1(1), 39-48, Mar. 2022
• 68(8), 283, Aug. 2022
• 27(1), 93, Jan. 2022

Case report
• [A Case Report of Severe Ischemic Priapism Treated Aggressively by Proximal Shunt]., Nishimura Nobutaka;Torimoto Kazumasa;Oda Yuki;Yoshida Takanori;Uematsu Toshitaka;Omori Chihiro;Fujimoto Kiyohide, Hinyokika kiyo. Acta urologica Japonica, 66(11), 411-414, Nov. 2020

  DOIPermalink
• A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib., Suzuki Issei;Kijima Toshiki;Takada-Owada Atsuko;Nakamura Gaku;Uematsu Toshitaka;Sakamoto Kazumasa;Nishihara Daisaku;Ishida Kazuyuki;Kamai Takao, IJU case reports, 4(6), 412-416, Nov. 2021

  DOIPermalink
• Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma., Nakagawa Takashi;Kijima Toshiki;Imasato Naoki;Nagoshi Akihiko;Nakamura Gaku;Uematsu Toshitaka;Suzuki Issei;Nishihara Daisaku;Kamai Takao, IJU case reports, 5(4), 293-296, Jul. 2022

  DOIPermalink
• Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava., Uematsu Toshitaka;Kijima Toshiki;Takada-Owada Atsuko;Nishihara Daisaku;Ishida Kazuyuki;Kamai Takao, Urology case reports, 45, 102205, Nov. 2022

  DOIPermalink
• A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab., Kokubun Hidetoshi;Kijima Toshiki;Takada-Owada Atsuko;Mamiya Daisuke;Kurashina Ryo;Okubo Naoya;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 6(6), 440-444, 14 Sep. 2023

  DOI
• A patient with oligometastatic hormone-sensitive prostate cancer who achieved long-term progression-free survival following cytoreductive radical prostatectomy and metastasectomy., Mamiya Daisuke;Kijima Toshiki;Takada-Owada Atsuko;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Kambara Tsunehito;Ishida Kazuyuki;Taneichi Hiroshi;Kamai Takao, IJU case reports, 7(2), 165-168, 29 Jan. 2024

  DOI
• Increased expression of ATP-binding cassette transporters in enfortumab vedotin-resistant urothelial cancer., Kotono Mariko;Kijima Toshiki;Takada-Owada Atsuko;Okubo Naoya;Kurashina Ryo;Kokubun Hidetoshi;Uematsu Toshitaka;Takei Kohei;Ishida Kazuyuki;Kamai Takao, IJU case reports, 7(2), 173-176, 29 Jan. 2024

  DOI